Sick of high drug prices, insurers join hospitals to make their own generic medications

23 January 2020 - Everyone complains about high drug prices. But hospitals — and now insurers — are trying to ...

Read more →

Update of the frequently asked questions for the PBS Botulinum Toxin Program

23 January 2020 - A revised version of the frequently asked questions for the PBS Botulinum Toxin Program is now available. ...

Read more →

Jazz Pharmaceuticals submits new drug application for JZP-258 for cataplexy and excessive daytime sleepiness associated with narcolepsy

22 January 2020 - Jazz Pharmaceuticals today announced the submission of a new drug application to the U.S. Food and Drug ...

Read more →

Reimbursement for Repatha to expand treatment options for ASCVD patients

22 January 2020 - Amgen is set to expand treatment options for atherosclerotic cardiovascular disease patients with Repatha, a high-cholesterol treatment, ...

Read more →

Roche wins approval for cancer drug Kadcyla in fast-growing China market

23 January 2020 - Roche said on Wednesday China had approved the import of its Kadcyla drug for breast cancer, another ...

Read more →

Morneau says Ottawa will need to work with provinces on issues like universal pharmacare

19 January 2020 - Finance Minister Bill Morneau said that the federal government will often need to work together with provinces ...

Read more →

Supernus announces FDA acceptance for review of new drug application for SPN-812 for the treatment of ADHD

21 January 2020 - PN-812 (viloxazine hydrochloride), a once-daily novel serotonin norepinephrine modulating agent, demonstrates a reduction in ADHD-RS-5 total score ...

Read more →

Court of Justice upholds EMA’s approach to transparency

22 January 2020 - EMA welcomes today’s two appellate judgments by the Court of Justice that confirmed, in clear and ...

Read more →

The FDA continues to struggle with the implications of approving Sarepta’s drugs

22 January 2020 - New documents released Wednesday lay bare the stark divide within the Food and Drug Administration regarding ...

Read more →

Competition, not capping increases, is the cure for high drug prices

22 January 2020 - Soaring prescription drug prices are putting financial pressure on families across the country.  ...

Read more →

Supreme Court refuses to fast-track a challenge to the Affordable Care Act

22 January 2020 - The Supreme Court on Tuesday denied a motion to fast-track a challenge to the Affordable Care ...

Read more →

Merck strengthens Gonal-f portfolio with approval for 150 IU pen in the European Union

22 January 2020 - New Gonal-f 150 IU pen provides additional flexibility and convenience at every stage of the patients’ stimulation ...

Read more →

NHS patients denied new lung cancer drug after another NICE deadlock

22 January 2020 - Certain untreated lung cancer patients on England’s NHS will have to make do with older drugs ...

Read more →

EU group calls for 'targeted actions' to mitigate impact of Brexit

22 January 2020 - Committee wants to ensure safe supply of drugs and medical devices. ...

Read more →

FDA accepts Evoke Pharma’s NDA resubmission for Gimoti

21 January 2020 - PDUFA Target Goal Date is 19 June 2020. ...

Read more →

NICE rejects Janssen’s Stelara on cost efficiency grounds

22 January 2020 - NICE has released a draft guidance not recommending Janssen’s Stelara (ustekinumab) for moderately to severely active ...

Read more →